Pill that went from $13 to $750 now has a $1 rival

6
Pill that went from $13 to $750 now has a $1 rival Brought to you by The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

Transcript of Pill that went from $13 to $750 now has a $1 rival

Page 1: Pill that went from $13 to $750 now has a $1 rival

Pill that went from $13 to $750 now has a $1

rival

Brought to you by

The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

Page 2: Pill that went from $13 to $750 now has a $1 rival

Contd…In a demonstration of arbitrary pricing of medicines, pyremethamine, used to treat protozoal infections, went from $13 to $750 a pill in the US, an over 5,000% increase, and down to $1per pill for a new version, all in a span of just over a month. The new $1 pill is being produced by a small San Diego-based company called Imprimis Pharmaceuticals. Daraprim, or branded pyremethamine, was bought from its producer by Turing Pharmaceuticals owned by a hedge fund manager Martin Shkreli, who then hiked the price to $750 becoming “the poster child for big pharmaceutical greed“.Despite widespread protest over the massive price hike of a 62-year-old off-patent drug, Shkreli failed to bring down the price after promising he would do so. Daraprim, which treats an uncommon parasitic infection, toxoplasmosis, is critical for treating immune compromised patients of HIVAIDS, cancer and pregnant women.

Brought to you by

The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

Page 3: Pill that went from $13 to $750 now has a $1 rival

Contd…Imprimis Pharmaceuticals is a compounding pharmacy , which in the US means a company which mixes approved drug ingredients to prepare medicines based on a doctor's prescription. This three-and-a-half year old company is producing a formulation of Daraprim's active ingredients, pyremethamine and leucovorin.The Imprimis formulation is not approved by the US Food and Drug Administration (FDA), but compounded formulations are allowed to be sold legally in the US as long as it is through a doctor's prescription. Compounding pharmacies do not need FDA approval unlike large pharma companies that mass produce drugs on complex production lines. The increasingly complicated regulations around FDA drug approval would have meant several years and millions of dollars for Imprimis and that would not have allowed it to keep the price affordable.

Brought to you by

The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

Page 4: Pill that went from $13 to $750 now has a $1 rival

This platform has been started by Parveen Kumar Chadha with the vision that nobody should suffer the way he has suffered because of lack and improper healthcare facilities in India. We need lots of funds manpower etc. to make this vision a reality please contact us. Join us as a member for a noble cause.

Brought to you by

The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

Page 5: Pill that went from $13 to $750 now has a $1 rival

Our views have increased the mark of the 2,25,000

Thank you viewers Looking forward for franchise, collaboration, partners.

Brought to you by

The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

Page 6: Pill that went from $13 to $750 now has a $1 rival

011-25464531 ,011-41425180 ,011-66217387

+91-9818308353+,91-9818569476

[email protected]

www.other-mother.in

https://www.facebook.com/pages/Other-Mother-Nursing-Crusade/224235031114989?ref=hl

http://www.linkedin.com/profile/view?id=326103341&trk=nav_responsive_tab_profile

https://twitter.com/othermotherindi

https://cparveen.wix.com/other-mother

A WORLDWIDE MISSITION

Contact Us-:

JOIN US

www.parveenchadha.com

The Nurses and attendants staff we provide for your healthy recovery for bookings Contact Us:-

We are also available on Justdial New Delhi.

Brought to you by